Funding Opportunities

A new Funding Opportunities widget is now available in myRESEARCHhome, a portal for the Duke research community. Using funding data curated by ORS, th...

Information and resources for COVID-19 funding opportunities

OVPR Planning Grants aim to enhance interactions between faculty and lower the barriers to planning and creating large research proposals.

The Grant Deadlines listing for August 2020 is now available from the Duke University Funding Opportunities website.

The National Comprehensive Cancer Network is collaborating with Pfizer on a new grant opportunity in support of biosimilars in oncology. 

NCCN and Eli Lilly and Company have issued an RFP to support preclinical, clinical and correlative studies of abemaciclib for breast cancer. 

NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional) Funding Agency: National Institutes of Health Thi...

Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research (R21 Clinical Trial Not Allowed) Funding Agency: National Institute...

Basic Research in Cancer Health Disparities (R01, R21 Clinical Trial Not Allowed) Funding Agency: National Institutes of Health This Funding Opp...

Oncology Co-Clinical Imaging Research Resources to Encourage Consensus on Quantitative Imaging Methods and Precision Medicine (U24 - Clinical Trial Op...

K22 Independent Clinical Trial Not Allowed

K22 Clinical Trial Required

Bass Connections, in partnership with the Margolis Center for Health Policy, is now accepting proposals for new rsearch projects related to COVID-19.

This pilot program is designed to facilitate novel clinical and translational research that applies or accelerates discovery into testing in clinical or population settings.